-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Axsome Therapeutics, Raises Price Target to $249

Benzinga·11/03/2026 17:21:01
语音播报
Morgan Stanley analyst Sean Laaman maintains Axsome Therapeutics (NASDAQ:AXSM) with a Equal-Weight and raises the price target from $247 to $249.